However, individuals with Type 2 diabetes and high liver fat had higher fasting glucose and insulin levels, lower GIRs, and a corresponding higher M/I index and sustained higher insulin levels throughout the protocol than those with low liver fat. This evidence concerns the gene INS and type 2 diabetes mellitus.